How Do I? Video series
In our award-winning series of short videos, cancer survivors and experts guide you through issues that you may face after a cancer diagnosis. Topics include:
Insurance and finances
Mental health
Nutrition
Personal care
Survivorship
Videos in Spanish
We hope you find these videos informative and helpful. We would really appreciate your feedback, which helps us to plan future videos and resources.
How Do I Manage Medical Debt? (2025)
Worried about medical debt during cancer treatment? You’re not alone. In this video, Kinika Young, Director of Legal Advocacy at Blood Cancer United, shares practical steps cancer patients can take to manage and reduce medical debt. From understanding your rights to navigating insurance denials and finding financial assistance, Kinika breaks down what you need to know to advocate for yourself and find support. Watch now to take control of your medical bills and get the help you deserve.
How Do I Understand 2025 Medicare Updates? (2024)
In the latest installment of the “How Do I?” insurance series, Bethany Lilly, the Executive Director of Public Policy at Blood Cancer United, discusses the 2025 changes to Medicare Part D/Medicare Advantage and the steps that Medicare enrollees will need to take to benefit. This video is beneficial to all Medicare enrollees who use prescription medications.
How Do I Understand Insurance Basics? (2024)
In this video, Monica Fawzy Bryant, Esq., of Triage Cancer, teaches you the basics of insurance and where you can purchase it within the United States.
How Do I Find Insurance on the Healthcare Marketplace? (2024)
In the second installment of our Insurance series, Monica Fawzy Bryant, Esq., of Triage Cancer, returns to teach you all about the healthcare marketplace in the United States and how to purchase insurance at www.Healthcare.gov.
How Do I Understand Qualifications for Medicaid? (2024)
In the third installment of the “How Do I?” Insurance series, Monica Fawzy Bryant, Esq., of Triage Cancer, addresses Medicaid and eligibility requirements in the United States.
How Do I Understand Medicare? (2024)
Triage Cancer's Monica Fawzy Bryant, Esq., returns for the fourth installment of our "How Do I?" Insurance series to demystify Medicare, Parts A, B, C and D, and eligibility requirements in the United States.
How Do I Choose the Best Insurance Plan for Me? (2024)
In the fifth video installment of the “How Do I?” insurance series, Monica Fawzy Bryant, Esq., of Triage Cancer, teaches you all about comparing insurance plans in the United States and how to pick a plan that is right for you.
How Do I Understand My Options After Losing Healthcare? (2024)
Monica Fawzy Bryant, Esq., of Triage Cancer, reviews the options available to you if you lose healthcare coverage in the United States and how to maintain your current coverage through COBRA or obtain new insurance. This is the sixth installment of the "How Do I?" Insurance series.
How Do I Find a Therapist? (2023)
In this video, Dr. Damion Davis, a cancer survivor nd licensed professional counselor, will share the benefits of professional therapy after a cancer diagnosis and tips on how to find the right therapist for you.
How Do I Use Breathing to Help Manage Anxiety? (2023)
In this video, Drew Stockton, a cancer survivor, takes you through a short breathing exercise that you can use whenever you feel anxious. Use this technique to feel more balanced when you are feeling “scanxiety”, in the infusion room, or anytime you experience uncertainty, anxiety or depression.
How Do I Eat Healthy Using Berries? (2024)
In this video, Casey Kang Head, a 3x ALL cancer survivor and cancer coach, will share the health benefits of berries and show you two easy, healthy recipes that you can make at home. Stay tuned for future recipes from Casey!
How Do I Eat Healthy Using Carrots? (2024)
In this video, Casey Kang Head, a cancer survivor, returns to share the health benefits of carrots and show you two easy, healthy recipes that you can make at home.
How Do I Eat Healthy Using Greek Yogurt? (2024)
Casey Kang Head, a cancer survivor, returns with more easy and healthy nutrition tips. This time, Casey shares the health benefits of greek yogurt and show you three easy, healthy recipes that you can make at home.
How Do I Shape and Fill In My Eyebrows? (2024)
Did cancer treatment cause thinning or loss of your eyebrows? In this video, Jared Lipscomb, an AML survivor and professional makeup artist will show you how to shape and fill in your eyebrows.
How Do I Find and Wear a Wig? (Caucasians) (2023)
Christina Kosyla, an AML cancer survivor and professional makeup artist, teaches you how to choose the right wig(s) for you, how to put it on, and how to style it to look like YOU again. Considerations are taken for textures, styles, and cap construction for caucasians.
How Do I Find and Wear a Wig? (POCs) (2023)
In this video, Jade Gibson, a cancer survivor, will teach you how to choose the right wig(s) for you, how to put it on, and how to style it to look like YOU again. Considerations are taken for textures, styles, and cap construction for people of color.
How Do I Exercise with Cancer? (2023)
In this video, Rori Zura, a cancer survivor and cancer exercise specialist, will share the benefits of exercise after a diagnosis. Rori will demonstrate a few light exercises you can do at home to promote wellness during treatment and into long-term survivorship.
How Do I Benefit from Palliative Care? (2025)
Could palliative care support you during cancer treatment and survivorship? What’s the difference between palliative care and hospice care? In this video, Amanda Monteiro, LMSW, of Mount Sinai Hospital in New York City, breaks down the benefits of palliative care and busts common myths—especially the idea that it’s only for end-of-life. Watch now to learn how palliative care can help cancer patients and their families thrive.
How Do I Find Survivorship Care? (2023)
In this video, Dr. Samantha Siegel, a cancer survivor and internal medicine doctor, will share how to build your own “survivorship care team”, that will meet your unique needs as a cancer survivor after treatment and into long-term survivorship.
Cómo Puedo-Usar mi respiración para manejar mi ansiedad?
En este video, Drew Stockton, un sobreviviente de cáncer, lo guiará a través de un breve ejercicio de respiración que puede usar en cualquier momento que se sienta ansioso. Utilice esta técnica para recuperar el equilibrio cuando sienta “escaneo-ansiedad”, en la sala de infusión, o en momentos de incertidumbre, ansiedad o depresión.
Our How Do I? series has been named a Digital Health Awards winner three years in a row!
Stars Will Twinkle, The Sun Will Shine
Follow Olivia and her family as she is diagnosed with leukemia, goes to the hospital for treatment, and returns to school.
LLS COVID-19 Antibody Research Study: Your Questions Answered
Please note, with the fast developing knowledge on this topic, some recommendations may change as new data emerges. Click here to access the latest LLS information and resources on COVID-19.
This program will update you on the results so far regarding LLS’s COVID-19 Antibody Research Study. In February 2021, LLS began to collect data regarding COVID 19 in the LLS patient registry. LLS understood that COVID antibody research needed to be done, and so, in February this study began and over the ensuing months, the Registry has had over 3,500 patients take part in this study. The LLS registry now is over 8,000 patients. The study is ongoing and will be continuing not only to understand the safety and efficacy of the vaccines, but soon some information about whether other parts of the immune system, besides antibodies, are important for a patient’s ability to respond to the vaccine.
Note: This video has been updated to include the Special Booster Update. To watch only the Special Booster Update, watch the second video on this page.
Speaker
Larry Saltzman, MD
Executive Research Director
The Leukemia & Lymphoma Society
LLS COVID-19 Antibody Study - Special Booster Update
Since the initial recording of this webinar, a 3rd dose of the COVID vaccine was approved for certain immunocompromised individuals. Dr. Saltzman is back to give information about the new FDA authorization and what this means for blood cancer patients.
Note: The full video above has been updated to include the Special Booster Update. The video below was pulled from the full video.
Program Support
Support for this program provided by BeiGene, Ltd.; Bristol Myers Squibb; Pharmacyclics, An AbbVie Company & Janssen Biotech and Pfizer Inc.
Treating Myelodysplastic Syndromes Transformation to Acute Myeloid Leukemia
1.0 CME Credit for physicians available until: October 27, 2025
1.0 CE Contact hour for nurses available until: December 19, 2025
1.0 CE Contact hour for nurse practitioners available until: December 19, 2025
Format: Non-interactive recorded webinar
Download Slides: Treating Myelodysplastic Syndromes Transformation to Acute Myeloid Leukemia
Target Audience
This activity is intended for hematologist/oncologists, oncology nurses, and other healthcare professionals involved in the care of patients with hematologic malignancies.
Educational Objectives
After completing this activity, the participant should be better able to:
- Provide an overview of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
- Explain the progression from MDS to AML, including the factors that influence the transformation and the clinical implications
- Discuss the diagnostic criteria for distinguishing MDS from AML
- Describe the treatment options and management strategies for both MDS and AML, including emerging therapies
- Review resources and education to support patients, caregivers, and healthcare professionals
Faculty
Aref Al-Kali, MD
Professor of Medicine
MDS Clinic Director
Acute Myeloid Group Chair
Section Head
Division of Hematology
Mayo Clinic
Rochester, MN
Jennifer Andres, MSN, RN, FNP-C
Outpatient Hematology Nurse Practitioner
Mayo Clinic
Phoenix, AZ
Continuing Education Information
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Education
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.5 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 24116976. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute Inc.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact Mary Vu via email at [email protected].
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.
Supporters
There is no commercial support associated with this CE activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: [email protected].
Bispecific Therapy: Advancing Patient Care through Targeted Treatment
Recorded on: March 11, 2025
1.0 CME Credit for physicians and physician associates/physician assistants available until: November 5, 2026
1.0 CE Contact hour for nurses available until: November 5, 2026
1 Interprofessional Continuing Education (IPCE) credit available until: November 5, 2026
Format: Non-interactive recorded webinar
Download: Bispecific Therapy: Advancing Patient Care Through Targeted Treatement (Slides)
Target Audience
This activity is intended for physicians, physician assistants/associates, and nurses engaged in the care of patients with hematologic malignancies.
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Describe the underlying science and mechanisms of bispecific therapies
- Identify current and emerging indications for bispecific therapies for hematologic malignancies
- Assess the clinical evidence on the efficacy, safety, and potential side effects of bispecific therapies
- Develop strategies for incorporating bispecific therapies into clinical practice
- Describe the treatment process and mechanisms to improve patient understanding, care, and involvement
- Discuss challenges and potential future advancements in bispecific antibody development
Faculty
Luciano Costa, MD, PhD
Professor of Medicine
Mary and Bill Battle Professor of Multiple Myeloma
The University of Alabama at Birmingham
Birmingham, AL
Elise Curry, BA, BSN, RN, OCN
Clinical Trial Nurse Navigator
Clinical Trial Support Center
The Leukemia & Lymphoma Society
Washington, DC
Peter Martin, MD
Professor of Medicine
Chief of the Lymphoma Program
Weill Cornell Medicine
New York, NY
Continuing Education Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The Leukemia & Lymphoma Society. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Method of Participation
Learners must participate in the entire activity, complete the post-assessment with a score of 70% or higher, and complete and submit the evaluation form to earn credit. Once completed, the certificate will be generated. If you have questions regarding the receipt of your certificate, please contact us via email at [email protected].
There are no fees for participating in or receiving credits for this activity.
Providers
This activity is jointly provided by The Leukemia & Lymphoma Society and Postgraduate Institute for Medicine.
Supporters
There is no commercial support associated with this activity.
Disclosure of Financial Relationships
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
- Luciano Costa reports Grant/Research Support from BMS, Johnson & Johnson, Pfizer, AbbVie, Caribou, Genentech, and Gracel, and Consultant/Advisory Board for BMS, Johnson & Johnson, Pfizer, AbbVie, Caribou, Genentech, Regeneron, Adaptive Biotechnologies, and Astra Zeneca.
- Peter Martin reports Consultant/Advisory Board for Abbvie, AstraZeneca, Beigene, BMS, Genentech, Janssen, Pepromene, and Merck
- Elise Curry reports Patient advisory board member for Viracta Pharmaceuticals with compensation provided to Blood Cancer United.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: [email protected].